(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 47.84% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 117.08%, and while it is forecast to beat the US market's average forecast revenue growth rate of 22.74%.
Zai Lab's revenue in 2025 is $441,629,000.On average, 11 Wall Street analysts forecast ZLAB's revenue for 2026 to be $727,142,912,624, with the lowest ZLAB revenue forecast at $551,000,231,072, and the highest ZLAB revenue forecast at $925,758,246,208. On average, 9 Wall Street analysts forecast ZLAB's revenue for 2027 to be $1,028,577,264,880, with the lowest ZLAB revenue forecast at $667,997,369,776, and the highest ZLAB revenue forecast at $1,441,036,692,800.
In 2028, ZLAB is forecast to generate $1,671,071,713,600 in revenue, with the lowest revenue forecast at $1,300,582,617,600 and the highest revenue forecast at $2,089,116,126,400.